Role of Clinical and Multimodality Neuroimaging in the Evaluation of Brain Death/Death by Neurologic Criteria and Recent Highlights from 2023 Updated Guidelines
Diagnostics · 18.06.2024 · 14 (12) · 1287
DOI: 10.3390/diagnostics14121287 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 18.06.2024. Verfasst von Pokhraj Prakashchandra Suthar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Radiology & Nuclear Medicine, Rush University Medical Center, Chicago, IL 60612, USA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose of Review: This review aims to provide a comprehensive overview of the diagnosis of brain death/death by neurologic criteria (BD/DNC) by emphasizing the clinical criteria established by the American Academy of Neurology (AAN) in light of their updated guidelines released in 2023. In this review, we will focus on the current implementation of ancillary tests including the catheter cerebral angiogram, nuclear scintigraphy, and transcranial Doppler, which provide support in diagnoses when clinical examination and apnea tests are inconclusive. Finally, we will also provide examples to discuss the implementation of certain imaging studies in the context of diagnosing BD/DNC. Recent Findings: Recent developments in the field of neurology have emphasized the importance of clinical criteria for diagnosing BD/DNC, with the AAN providing clear updated guidelines that include coma, apnea, and the absence of brainstem reflexes. Current ancillary tests, including the catheter cerebral angiogram, nuclear scintigraphy, and transcranial Doppler play a crucial role in confirming BD/DNC when the clinical assessment is limited. The role of commonly used imaging studies including computed tomography and magnetic resonance angiographies of the brain as well as CT/MR perfusion studies will also be discussed in the context of these new guidelines. Summary: BD/DNC represents the permanent cessation of brain functions, including the brainstem. This review article provides the historical context, clinical criteria, and pathophysiology that goes into making this diagnosis. Additionally, it explores the various ancillary tests and selected imaging studies that are currently used to diagnose BD/DNC under the newly updated AAN guidelines. Understanding the evolution of how to effectively use these diagnostic tools is crucial for healthcare professionals who encounter these BD/DNC cases in their practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diagnostic Radiology & Nuclear Medicine, Rush University Medical Center, Chicago, IL 60612, USA.
ORCID-Profile: Miral D Jhaveri
Zitieren
APA
Suthar, P. P., Jhaveri, M. D., Kounsal, A., Pierce, L. D., & Singh, J. S. (2024). Role of Clinical and Multimodality Neuroimaging in the Evaluation of Brain Death/Death by Neurologic Criteria and Recent Highlights from 2023 Updated Guidelines. Diagnostics, 14(12), 1287. https://doi.org/10.3390/diagnostics14121287
Vancouver
Suthar PP, Jhaveri MD, Kounsal A, Pierce LD, Singh JS. Role of Clinical and Multimodality Neuroimaging in the Evaluation of Brain Death/Death by Neurologic Criteria and Recent Highlights from 2023 Updated Guidelines. Diagnostics. 2024;14(12):1287. doi:10.3390/diagnostics14121287
BibTeX
@article{Suthar2024,
author = {Suthar, Pokhraj Prakashchandra and Jhaveri, Miral D and Kounsal, Avin and Pierce, Lillian D and Singh, Jagadeesh S},
title = {Role of Clinical and Multimodality Neuroimaging in the Evaluation of Brain Death/Death by Neurologic Criteria and Recent Highlights from 2023 Updated Guidelines},
journal = {Diagnostics},
year = {2024},
volume = {14},
number = {12},
pages = {1287},
doi = {10.3390/diagnostics14121287}
}
EUVIMED